Skip to main content

Table 1 Patient demographics

From: Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study

Characteristic, n (%)

Early responders n = 332

Later responders n = 253

Patients without Halm-based assessment of TCS n = 1454

Age, years, mean (SD) [median]

63.8 (19.0) [68]

64.5 (18.2) [69]

64.7 (18.5) [68]

 ≥ 65 years

187 (55.8)

137 (54.2)

827 (56.9)

Sex, male

204 (61.4)

144 (56.9)

848 (58.3)

Ethnic origin

 White

225 (67.8)

217 (85.8)

1131 (77.8)

 Non-white

8 (2.4)

3 (1.2)

40 (2.8)

 Unknown/missing

9 (2.7)

3 (1.2)

39 (2.7)

 Not applicable*

90 (27.1)

30 (11.9)

244 (16.8)

Previous admission to hospital with CAP (last 3 months)

8 (2.4)

9 (3.6)

82 (5.6)

Haemodialysis

0

1 (0.4)

5 (0.3)

Chemotherapy for active cancer

1 (0.3)

1 (0.4)

28 (1.9)

Smoking status

 Non-smoker

129 (38.5)

108 (42.7)

467 (32.1)

 Ex-smoker

94 (28.1)

79 (31.2)

380 (26.1)

 Occasional smoker

2 (0.6)

2 (0.8)

38 (2.6)

 Habitual smoker

89 (26.8)

46 (18.2)

328 (22.6)

 Unknown

18 (5.4)

18 (7.1)

241 (16.6)

  1. *All patients in this category were from France, where this question is not permitted in clinical studies.
  2. Definitions: Never smoked: patients who have never smoked > 20 g of tobacco in their lifetime; Ex-smoker: patients who stopped smoking ≥ 365 days ago: Occasional smoker: patients who smoke < 1 tobacco product per day; Habitual smoker: patients who smoke ≥ 1 tobacco products/day.
  3. SD = standard deviation; TCS = time to clinical stability.